Blood testing products for brain diseases

ZelosDx is pioneering a novel approach to brain disease diagnostics through its patented technology, "Window into the Brain™." This innovative method leverages the unique properties of phagocytic cells, which are recruited to the brain to clear neurodegenerative debris. These cells can re-enter the bloodstream, allowing researchers to obtain brain-derived biomarkers from a simple blood sample. This capability not only facilitates the detection of biomarkers in patients with neurological diseases but also in healthy individuals, providing a rich source of information about recent brain damage. The short lifespan of these phagocytes makes their content a valuable indicator of active neurodegeneration, effectively serving as a non-invasive brain biopsy that reveals pathological changes in the brain.

The technology addresses a significant gap in the current healthcare landscape, where neurological diseases and trauma affect millions and incur substantial costs. ZelosDx's focus on developing low-cost blood testing products aims to enhance research and drug development by providing critical biomarkers that can expedite the drug development process and improve trial success rates. By enabling early detection and monitoring of brain health, the "Window into the Brain™" technology holds the potential to transform the management of neurological disorders, ultimately leading to better patient outcomes and reduced healthcare expenditures.

United States

ZelosDx, previously MSDx, Inc. is developing blood testing products to help researchers make breakthrough discoveries in brain health and disease.
We seek research collaborators to license and adapt our proprietary technology for blood testing kits and automated laboratory equipment, and pharmaceutical collaborators seeking biomarker technology for drug discovery tools to be used as endpoints in their clinical trials in these neurodegenerative markets. The company is looking to make the right partnering or licensing connection!

ZelosDx

Company Details